Supplimentary 2 : Key Features of the Studies Included in This Review

Supplimentary 2 : Key features of the studies included in this review

AuthorLocation / StudyStudySample MSOverall PrevalenceMS components Setting Year Design Size Definitions Prevalence

1Zahid Pakistan/2006 Cross-sectional1658 IDF,IDF: 40%High FPG: 18.3%

et al. 2008rural(≥20 yrs)ATPIII(M:13%, F:50%)(M: 14.7%,F:20.4%)

F: 63.9%ATPIII: 31%Low HDL: 79.6%

(M:20%, F:40%)(M:72.8%,F:83.4%)

High TG: 29.4%

(M:24.3%,F:32.2%)

2.SharmaNepalNM Cross-sectional2191IDF, IDF:22.5%Available only in

et al. 2011(≥20 yrs)ATPIII(M:17.1%, F:25.7%)figure without F: 63.2% ATPIII: 20.7% providing exact (M:18.6%,F:21.9%) proportion

3.Rahim Bangladesh/2004 Cross-sectional3981 IDF,IDF: 11.2%NM

et al. 2007rural(≥20 yrs)ATPIII,(M:4.3%, F:15.7%) F: 59.9% WHO ATPIII: 20.7% (M:14.3%, F:25.1%) WHO: 8.6% (M:7.6%,F:9.2%)

4.Bhowmik Bangladesh/2009 Cross-sectional2293 ATPIIIATPIII: 30.7%NM

et al.2013rural(≥20 yrs)(M:30%, F:31.1%)

F: 63.3%

5.KatulandaSri Lanka/2005/6 Cross-sectional4485 IDFIDF: 27.1%HT: 81.1%

et al. 2012urban &rural(≥18 yrs)(M:18.4%, F:28.3%)Low HDL: 77.0%

F: 60.5%Age-adjustedHigh TG: 55.1%

Overall: 24.3%

Urban: 34.8%, Rural: 21.6%

6.Chackrewarthy Sri Lanka/2007 Cross-sectional2985IDF,Age & Sex adjustedHigh FPG: 65.1%

et al. 2013 urban(35-65yrs)ModifiedMo. ATPIII: 46.1%(M:66.5% F: 63.9% F:54.5% ATPIII (M:33.9%,F:56.1%) HT: 57.8%

IDF: 38.9%(M:56.3%,F:58.9%)

(M:22.9%,F:45.8%)CO (Asian WC cut-off):

54.4%

(M:35.1%,F:70.2%) Low HDL: 31.6% (M:7.4%,F: 51.5%) High TG: 31% (M:33%,F:27.6%)

7.Deepa India/NM Cross-sectional2350 IDF,IDF: 25.8%High FPG: 20.9%(IDF),

et al. 2007urban(≥20 yrs)ATPIII,(M:23.1%, F:28.2%14.7%(ATPIII)

F: 53%WHOATPIII: 18.3%CO:57%(WHO),49.2%

(M:17.1%, F:19.4%)(IDF), 18.5% (ATPIII) WHO: 23.2% HT: 20% (WHO), (M:27.3%, F:19.7%) 31.2% (IDF, ATPIII)

High TG: 25.2%

(M:31%,F:20.1%)

Low HDL:63.5%

(M:55.4%,F:70.6%)

Dyslipidemia: 41.7%

(WHO)

8.Gupta India/NM Cross-sectional1091ATPIIIATPIII:31.6%High FPG: 16.5%

et al. 2004urban(≥20 yrs)(M:22.9%, F:39.9%)(M:16.9%,F:16.1%)

F: 51.2%Age adjustedHT: 47.2%

Overall: 24.9%(M:41.4%,F:40%) (M:18.4%,F:30.9%) Low HDL: 72.9%

(M:54.9%,F:90.2%) High TG: 30.4% (M: 32.3%,F:28.6%) CO: 33.2% (M:21.8%, F:44%)

9.Gupta India/2008/10 Cross-sectional739 ATP IIIAge-adjustedHigh FPG: 13.4%

et al. 2012urban(20-59 yrs)ATPIII: 24.2%(M:15.5%,F:10.8%)

F: 38.9%(M:25.1%, F:22%)HT: 34.4%

(M:39.5%,F:24.6%) High TG: 32.8% (M:37.6%,F:23.1%) Low HDL: 31.7% (M:25.1%,F:43.7%)

CO:18.1% (M:12.9%,F:26.6%)

10.Misra India/2005/7 Cross-sectional1082 IDF,IDF: 23.9%High FPG: 28%

et al. 2011urban & rural(≥ 18 yrs)ATPIII(M:20.6%,F:26.1%)(M:33.1%,F:24.6%)

F: 60%ATP III: 18.9%HT: 30% (M: 12.3%,,F: 23.5%) (M:33.3%,F:27.8%) Low HDL: 31.9% (M:2.8%,F:51.2%) High TG: 30.9% (M: 35.9%,F: 27.5%) CO: 22.2% (M:12.3%,F:28.8%) CO (Asian WC cut-off): 43.8% (M:40.3%,F:46.1%)

11.Prabhakaran India/1991/95 Cross-sectional4044ATPIII,Age-adjustedHigh FPG:9.2%,

et al. 2007urban & rural(35-64 yrs)ModifiedATPIII:24.6%(M:10.1%,F:8.3%)

F: 51.9%ATP III(M:22.2%,F:26.8%)HT: 22.9% Mo.ATPIII:27.1% (M:22.2%,F:23.6%)

(M:27.4%,F:26.8%)Low HDL: 68.3% (M:58%,F:78%) High TG: 38.9% (M: 41.4%,F: 36.7%) CO: 14.3% (M:9.4%, F: 18.9%)

12.RavikiranIndia/NM Cross-sectional2225ATPIII,ATPIII:35.8%High FPG: 40.1%

et al. 2010urban(≥20 yrs)Modified(M:27.7%,F:43.2%)(M:38.5%,F:41.6%)

F: 52%ATPIII,Mo. ATPIII:45.3%HT: 58.5%

IDF(M:39.2%,F:50.9%)(M:61.9%,F:55.4%)

IDF: 39.8%Low HDL: 45.5%

(M:31.8%,F:47.2%)(M:27.2%,F:62.4%)

Age-adjustedHigh TG: 39.1% ATPIII:16.9% (M:39%,F:39.1%) Mo. ATPIII: 22.3% CO (Asian WC cut-off): IDF: 19.4% 60.3%

(M:52.2%,F:67.8%)

CO:31.6%

(M:16.3%, F: 45.6%)

13.SarkarIndia/NM Cross-sectional563ATPIIIATP III: 25.7%High FPG: 10.5%

et al. 2005urban & rural(>20 yrs)(M:20.9%, F:51.4%)(M:11.6%,F:9.5%)

F: 54.2%High TG: 42.8%

(M:52%, F: 60.4%) Low HDL: 74.2% (M:61.2%, F: 85.2%) CO: 13.3% (M: 1.5%,F: 23.3%)

14.SawantIndia/NM Cross-sectional548ModifiedMo.ATP III: 19.5%High FPG: 39.9

et al. 2011urban(>20 yrs)ATP III(M:25.2%, F:12.6%)High TG: 38.1% F: 44.8% Low HDL: 47.9%

CO (Asian WC-cut off): 70.9%

15.FallIndia/ 1998/2002 Longitudinal1492ModifiedMo. ATPIII: 29.1%High FPG: 39.3%

et al. 2008urban(26-32 yrs)ATP III(M:35.6%, F:20.2%)(M:41.3%,F:36.6%)

F: 41.7%High TG: 28.4%

(M:41.2%, F: 10.6%) Low HDL: 43% (M:34.2%, F: 55.6% CO (Asian WC cut-off): 48.9%, (M:51.5%, F:45.5%)

16.Prasad India/ 2001 Cross-sectional1178ModifiedMo. ATPIII: 43.2%High FPG: 31.2%

et al. 2012urban(>20 yrs)ATP III(M:34.2%, F:52.2%)(M:33.4%,F:42.3%)

F: 49.9%Age-adjustedHigh TG: 37.7%

Mo. ATPIII: 33.5%(M:39.3%, F: 36.1%) (M:24.9%, F:42.3%) Low HDL: 46.9% (M:9.5%, F: 84.5%) HT: 63.1%

(M:69.3%, F: 56.8%)

CO (Asian WC cut-off): 48.9% (M:41.9%, F: 56.0%)

Abbreviations: MS: Metabolic Syndrome, NM: Not Mentioned, High FPG: High Fasting Plasma Glucose, High TG: High Triyglycerides, HT: Hypertension, CO: Central Obesity, Low HDL: Low High Density Lipoprotein, WC: Waist Circumference